SCHEMBL6448102

SCHEMBL6448102

NC(=O)c1ccccc1-c1ccc(-c2ccncc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.67
CHUK O15111 4/20 0.59
IKBKB O14920 4/20 0.59
IKBKE Q14164 2/20 0.59
PKMYT1 Q99640 1/20 0.59
ALDH1A1 P00352 1/20 0.51
PARP1 P09874 1/20 0.51
PARP2 Q9UGN5 1/20 0.51
CDC7 O00311 7/20 0.50
ROCK2 O75116 2/20 0.50
MAP4K4 O95819 2/20 0.50
CLK4 Q9HAZ1 2/20 0.50
MKNK2 Q9HBH9 2/20 0.50
GSK3B P49841 1/20 0.50
CSNK1A1 P48729 1/20 0.49
TYRO3 Q06418 1/20 0.49
DYRK1B Q9Y463 1/20 0.49
CCNA2 P20248 1/20 0.48
CDK2 P24941 1/20 0.48
CCNA1 P78396 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL164881 0.96 BCAT2 (0.71) BCAT2CHUKIKBKBIKBKEPKMYT1
Hydrochloric Acid SCHEMBL4597839 0.95 BCAT2 (0.69) BCAT2CHUKIKBKBIKBKEPKMYT1
Hydrochloric Acid SCHEMBL29710331 0.95 BCAT2 (0.69) BCAT2CHUKIKBKBIKBKEPKMYT1
Hydrochloric Acid SCHEMBL9027847 0.95 BCAT2 (0.69) BCAT2CHUKIKBKBIKBKEPKMYT1
SCHEMBL30582476 0.89 BCAT2 (0.83) BCAT2CHUKIKBKBALDH1A1CSNK1A1
SCHEMBL28529048 0.87 CHUK (0.56) BCAT2CHUKIKBKBIKBKEPKMYT1
SCHEMBL5878337 0.87 BCAT2 (0.87) BCAT2IKBKBALDH1A1PARP1CSNK1A1
Pyridine SCHEMBL28666919 0.86 BCAT2 (0.79) BCAT2CHUKIKBKBIKBKEPKMYT1
SCHEMBL31140008 0.85 BCAT2 (0.92) BCAT2CHUKIKBKBIKBKEPKMYT1
SCHEMBL7143118 0.81 CHUK (0.61) BCAT2CHUKIKBKBIKBKEPKMYT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050080084-A1 Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of central nervous system damage PHARMACIA CORPORATION 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080084-A1 Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of central nervous system damage TPH2, TPH1, HTR2A BCAT2 2228/4885CHUK 132/4885IKBKB 196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.